• Media type: E-Article
  • Title: Brigatinib (BRG) in crizotinib (CRZ)-refractory ALK+ non–small cell lung cancer (NSCLC): Efficacy updates and exploratory analysis of CNS ORR and overall ORR by baseline (BL) brain lesion status
  • Contributor: Huber, Rudolf M.; Kim, Dong-Wan; Ahn, Myung-Ju; Langer, Corey J.; Tiseo, Marcello; West, Howard; Groen, Harry J.M.; Reckamp, Karen L.; Hochmair, Maximilian J.; Leighl, Natasha B.; Holmskov Hansen, Karin; Gettinger, Scott N.; Paz-Ares, Luis G.; Kim, Edward S.; Smit, Egbert F.; Kim, Sang-We; Reichmann, William; Kerstein, David; Camidge, D. Ross
  • imprint: American Society of Clinical Oncology (ASCO), 2018
  • Published in: Journal of Clinical Oncology
  • Language: English
  • DOI: 10.1200/jco.2018.36.15_suppl.9061
  • ISSN: 0732-183X; 1527-7755
  • Keywords: Cancer Research ; Oncology
  • Origination:
  • Footnote:
  • Access State: Open Access